SCHEMBL903658

SCHEMBL903658

COc1ccc2c(c1)OC(C)(C)c1c-2[nH]c2ccc(OC)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 2/20 0.49
KDM4E B2RXH2 6/20 0.47
ALDH1A1 P00352 5/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 4/20 0.47
HSD17B10 Q99714 3/20 0.47
TSHR P16473 2/20 0.47
GFER P55789 1/20 0.47
HPGD P15428 4/20 0.46
LMNA P02545 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
CCNC P24863 2/20 0.41
CDK8 P49336 2/20 0.41
HASPIN Q8TF76 2/20 0.41
ALOX5 P09917 1/20 0.40
CA1 P00915 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL903731 0.70 ALDH1A1 (0.43) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL1985544 0.70 MEN1 (0.51) MAPKAPK2KDM4EALDH1A1MEN1KMT2A
SCHEMBL18215247 0.69 KMT2A (0.45) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL29391519 0.67 ALDH1A1 (1.00) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL2597652 0.67 ALDH1A1 (1.00) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL13391226 0.67 CA1 (0.42) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL1986560 0.65 CCNB2 (0.56) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL6365456 0.64 MEN1 (0.65) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL14772234 0.64 CCNB2 (0.41) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL903534 0.64 ALOX5 (0.53) KDM4EALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041227-A1 TETRACYCLIC HETEROCYCLE COMPOUNDS FOR TREATING HEPATITIS C VIRAL INFECTION MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed
WO-2012040924-A1 FUSED TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed